ホーム > 市場調査レポート > 医薬品

呼吸器

市場調査レポート

商品コード

1506625

慢性咳嗽 - 市場考察、疫学、市場予測（2034年）

Chronic Cough - Market Insight, Epidemiology, and Market Forecast - 2034

出版日: 2024年06月01日
発行: DelveInsight医薬品関連専門
ページ情報: 英文 200 Pages
納期: 2～10営業日

カスタマイズ可能

適宜更新あり

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

当レポートでは、慢性咳嗽の主要7市場（米国、ドイツ、スペイン、イタリア、フランス、英国、日本）について調査分析し、各地域の市場規模、現在の治療法、アンメットニーズ、新治療法などの情報を提供しています。

疫学の主な調査結果
前提条件と根拠：主要7市場
疫学シナリオ：主要7市場
- 主要7市場の慢性咳嗽の疫学シナリオ（2020年～2034年）
米国の疫学
- 米国の慢性咳嗽の疫学シナリオ（2020年～2034年）
欧州5ヶ国の疫学：国別
- ドイツの疫学
- フランスの疫学
- イタリアの疫学
- スペインの疫学
- 英国の疫学
- 日本の疫学

第8章治療アルゴリズム、現在の治療、医療行為

慢性咳嗽の治療と管理
慢性咳嗽の治療アルゴリズム

第9章アンメットニーズ

第10章慢性咳嗽治療の主な評価項目

第11章上市済みの製品

第12章新治療法

第13章慢性咳嗽：主要7市場の分析

主な調査結果
主要7市場の慢性咳嗽の市場規模
主要7市場の慢性咳嗽の市場規模：治療法別

第14章属性分析

第15章主要7市場：市場見通し

米国：市場規模
- 米国の慢性咳嗽の総市場規模
- 米国の慢性咳嗽の市場規模：治療法別
欧州5ヶ国：市場規模と見通し
ドイツの市場規模
- ドイツの慢性咳嗽の総市場規模
- ドイツの慢性咳嗽の市場規模：治療法別
フランスの市場規模
イタリアの市場規模
スペインの市場規模
英国の市場規模
- 英国の慢性咳嗽の総市場規模
- 英国の慢性咳嗽の市場規模：治療法別
日本市場の見通し
- 日本の市場規模

第16章慢性咳嗽のアクセスと償還の概要

第17章 KOLの見解

第18章市場促進要因

第19章市場の障壁

第20章付録

第21章 DelveInsightのサービス内容

第22章免責事項

第23章 DelveInsightについて

図表

List of Tables

Table 1: 7MM Chronic Cough Epidemiology (2020-2034)
Table 2: 7MM Chronic Cough Diagnosed and Treatable Cases (2020-2034)
Table 3: Chronic Cough Epidemiology in the United States (2020-2034)
Table 4: Chronic Cough Diagnosed and Treatable Cases in the United States (2020-2034)
Table 5: Chronic Cough Epidemiology in Germany (2020-2034)
Table 6: Chronic Cough Diagnosed and Treatable Cases in Germany (2020-2034)
Table 7: Chronic Cough Epidemiology in France (2020-2034)
Table 8: Chronic Cough Diagnosed and Treatable Cases in France (2020-2034)
Table 9: Chronic Cough Epidemiology in Italy (2020-2034)
Table 10: Chronic Cough Diagnosed and Treatable Cases in Italy (2020-2034)
Table 11: Chronic Cough Epidemiology in Spain (2020-2034)
Table 12: Chronic Cough Diagnosed and Treatable Cases in Spain (2020-2034)
Table 13: Chronic Cough Epidemiology in the UK (2020-2034)
Table 14: Chronic Cough Diagnosed and Treatable Cases in the UK (2020-2034)
Table 15: Chronic Cough Epidemiology in Japan (2020-2034)
Table 16: Chronic Cough Diagnosed and Treatable Cases in Japan (2020-2034)
Table 17: Drug Name, Clinical Trials by Recruitment status
Table 18: Drug Name, Clinical Trials by Zone
Table 19: Total Seven Major Market Size in USD, Million (2020-2034)
Table 20: Region-wise Market Size in USD, Million (2020-2034)
Table 21: 7MM-Market Size by Therapy in USD, Million (2020-2034)
Table 22: United States Market Size in USD, Million (2020-2034)
Table 23: United States Market Size by Therapy in USD, Million (2020-2034)
Table 24: Germany Market Size in USD, Million (2020-2034)
Table 25: Germany Market Size by Therapy in USD, Million (2020-2034)
Table 26: France Market Size in USD, Million (2020-2034)
Table 27: France Market Size by Therapy in USD, Million (2020-2034)
Table 28: Italy Market Size in USD, Million (2020-2034)
Table 29: Italy Market Size by Therapy in USD, Million (2020-2034)
Table 30: Spain Market Size in USD, Million (2020-2034)
Table 31: Spain Market Size by Therapy in USD, Million (2020-2034)
Table 32: United Kingdom Market Size in USD, Million (2020-2034)
Table 33: United Kingdom Market Size by Therapy in USD, Million (2020-2034)
Table 34: Japan Market Size in USD, Million (2020-2034)
Table 35: Japan Market Size by Therapy in USD, Million (2020-2034)

The list of tables is not exhaustive; the final content may vary

List of Figures

Figure 1: 7MM Chronic Cough Epidemiology (2020-2034)
Figure 2: 7MM Chronic Cough Diagnosed and Treatable Cases (2020-2034)
Figure 3: Chronic Cough Epidemiology in the United States (2020-2034)
Figure 4: Chronic Cough Diagnosed and Treatable Cases in the United States (2020-2034)
Figure 5: Chronic Cough Epidemiology in Germany (2020-2034)
Figure 6: Chronic Cough Diagnosed and Treatable Cases in Germany (2020-2034)
Figure 7: Chronic Cough Epidemiology in France (2020-2034)
Figure 8: Chronic Cough Diagnosed and Treatable Cases in France (2020-2034)
Figure 9: Chronic Cough Epidemiology in Italy (2020-2034)
Figure 10: Chronic Cough Diagnosed and Treatable Cases in Italy (2020-2034)
Figure 11: Chronic Cough Epidemiology in Spain (2020-2034)
Figure 12: Chronic Cough Diagnosed and Treatable Cases in Spain (2020-2034)
Figure 13: Chronic Cough Epidemiology in the UK (2020-2034)
Figure 14: Chronic Cough Diagnosed and Treatable Cases in the UK (2020-2034)
Figure 15: Chronic Cough Epidemiology in Japan (2020-2034)
Figure 16: Chronic Cough Diagnosed and Treatable Cases in Japan (2020-2034)
Figure 17: Drug Name, Clinical Trials by Recruitment status
Figure 18: Drug Name, Clinical Trials by Zone
Figure 19: Total Seven Major Market Size in USD, Million (2020-2034)
Figure 20: Region-wise Market Size in USD, Million (2020-2034)
Figure 21: 7MM-Market Size by Therapy in USD, Million (2020-2034)
Figure 22: United States Market Size in USD, Million (2020-2034)
Figure 23: United States Market Size by Therapy in USD, Million (2020-2034)
Figure 24: Germany Market Size in USD, Million (2020-2034)
Figure 25: Germany Market Size by Therapy in USD, Million (2020-2034)
Figure 26: France Market Size in USD, Million (2020-2034)
Figure 27: France Market Size by Therapy in USD, Million (2020-2034)
Figure 28: Italy Market Size in USD, Million (2020-2034)
Figure 29: Italy Market Size by Therapy in USD, Million (2020-2034)
Figure 30: Spain Market Size in USD, Million (2020-2034)
Figure 31: Spain Market Size by Therapy in USD, Million (2020-2034)
Figure 32: United Kingdom Market Size in USD, Million (2020-2034)
Figure 33: United Kingdom Market Size by Therapy in USD, Million (2020-2034)
Figure 34: Japan Market Size in USD, Million (2020-2034)
Figure 35: Japan Market Size by Therapy in USD, Million (2020-2034)

The list of figures is not exhaustive; the final content may vary

Product Code: DIMI1334

DelveInsight's "Chronic Cough - Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Chronic Cough, historical and forecasted epidemiology as well as the Chronic Cough market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Chronic Cough market report provides current treatment practices, emerging drugs, Chronic Cough market share of the individual therapies, current and forecasted Chronic Cough market size from 2020 to 2034 segmented by seven major markets. The Report also covers current Chronic Cough treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Geography Covered:

The United States
EU5 (Germany, France, Italy, Spain, and the United Kingdom)
Japan

Study Period: 2020-2034

Chronic Cough Disease Understanding and Treatment Algorithm

The DelveInsight Chronic Cough market report gives a thorough understanding of the Chronic Cough by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.

Diagnosis

This segment of the report covers the detailed diagnostic methods or tests for Chronic Cough.

Treatment

It covers the details of conventional and current medical therapies available in the Chronic Cough market for the treatment of the condition. It also provides Chronic Cough treatment algorithms and guidelines in the United States, Europe, and Japan.

Chronic Cough Epidemiology

The Chronic Cough epidemiology division provide insights about historical and current Chronic Cough patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Chronic Cough epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2020 to 2034.

Country Wise-Chronic Cough Epidemiology

The epidemiology segment also provides the Chronic Cough epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Chronic Cough Drug Chapters

Drug chapter segment of the Chronic Cough report encloses the detailed analysis of Chronic Cough marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Chronic Cough clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Marketed Drugs

The report provides the details of the marketed product available for Chronic Cough treatment.

Chronic Cough Emerging Drugs

The report provides the details of the emerging therapies under the late and mid-stage of development for Chronic Cough treatment.

Chronic Cough Market Outlook

The Chronic Cough market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Chronic Cough market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

This segment gives a thorough detail of Chronic Cough market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, Chronic Cough market in 7MM is expected to change in the study period 2020-2034.

Key Findings

This section includes a glimpse of the Chronic Cough market in 7MM.

The United States Market Outlook

This section provides the total Chronic Cough market size and market size by therapies in the United States.

EU-5 Countries: Market Outlook

The total Chronic Cough market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.

Japan Market Outlook

The total Chronic Cough market size and market size by therapies in Japan is also mentioned.

Chronic Cough Drugs Uptake

This section focusses on the rate of uptake of the potential drugs recently launched in the Chronic Cough market or expected to get launched in the market during the study period 2020-2034. The analysis covers Chronic Cough market uptake by drugs; patient uptake by therapies; and sales of each drug.

This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Chronic Cough Pipeline Development Activities

The report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Chronic Cough key players involved in developing targeted therapeutics.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing, patent details and other information for Chronic Cough emerging therapies.

Reimbursement Scenario in Chronic Cough

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

KOL- Views

To keep up with current market trends, we take KOLs and SME's opinion working in Chronic Cough domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Chronic Cough market trend. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Competitive Intelligence Analysis

We perform Competitive and Market Intelligence analysis of the Chronic Cough Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Report:

The report covers the descriptive overview of Chronic Cough, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
Comprehensive insight has been provided into the Chronic Cough epidemiology and treatment in the 7MM
Additionally, an all-inclusive account of both the current and emerging therapies for Chronic Cough are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
A detailed review of Chronic Cough market; historical and forecasted is included in the report, covering drug outreach in the 7MM
The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Chronic Cough market

Report Highlights:

In the coming years, Chronic Cough market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
The companies and academics are working to assess challenges and seek opportunities that could influence Chronic Cough R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
Major players are involved in developing therapies for Chronic Cough. Launch of emerging therapies will significantly impact the Chronic Cough market
A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Chronic Cough
Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Chronic Cough Report Insights

Patient Population
Therapeutic Approaches
Chronic Cough Pipeline Analysis
Chronic Cough Market Size and Trends
Market Opportunities
Impact of upcoming Therapies

Chronic Cough Report Key Strengths

11 Years Forecast
7MM Coverage
Chronic Cough Epidemiology Segmentation
Key Cross Competition
Highly Analyzed Market
Drugs Uptake

Chronic Cough Report Assessment

Current Treatment Practices
Unmet Needs
Pipeline Product Profiles
Market Attractiveness
Market Drivers and Barriers

Key Questions:

Market Insights:

What was the Chronic Cough market share (%) distribution in 2020 and how it would look like in 2034?
What would be the Chronic Cough total market size as well as market size by therapies across the 7MM during the forecast period (2024-2034)?
What are the key findings pertaining to the market across 7MM and which country will have the largest Chronic Cough market size during the forecast period (2024-2034)?
At what CAGR, the Chronic Cough market is expected to grow in 7MM during the forecast period (2020-2034)?
What would be the Chronic Cough market outlook across the 7MM during the forecast period (2020-2034)?
What would be the Chronic Cough market growth till 2032, and what will be the resultant market Size in the year 2034?
How would the market drivers, barriers and future opportunities affect the market dynamics and subsequent analysis of the associated trends?

Epidemiology Insights:

What is the disease risk, burden and unmet needs of the Chronic Cough?
What is the historical Chronic Cough patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
What would be the forecasted patient pool of Chronic Cough in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Chronic Cough?
Out of all 7MM countries, which country would have the highest prevalent population of Chronic Cough during the forecast period (2020-2034)?
At what CAGR the population is expected to grow in 7MM during the forecast period (2020-2034)?

Current Treatment Scenario, Marketed Drugs and Emerging Therapies:

What are the current options for the Chronic Cough treatment, along with the approved therapy?
What are the current treatment guidelines for the treatment of Chronic Cough in the USA, Europe, and Japan?
What are the Chronic Cough marketed drugs and their MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
How many companies are developing therapies for the treatment of Chronic Cough?
How many therapies are developed by each company for Chronic Cough treatment?
How many are emerging therapies in mid-stage, and late stage of development for Chronic Cough treatment?
What are the key collaborations (Industry - Industry, Industry - Academia), Mergers and acquisitions, licensing activities related to the Chronic Cough therapies?
What are the recent novel therapies, targets, mechanisms of action and technologies developed to overcome the limitation of existing therapies?
What are the clinical studies going on for Chronic Cough and their status?
What are the key designations that have been granted for the emerging therapies for Chronic Cough?
What are the global historical and forecasted market of Chronic Cough?

Reasons to buy:

The report will help in developing business strategies by understanding trends shaping and driving the Chronic Cough market
To understand the future market competition in the Chronic Cough market and Insightful review of the key market drivers and barriers
Organize sales and marketing efforts by identifying the best opportunities for Chronic Cough in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
Organize sales and marketing efforts by identifying the best opportunities for Chronic Cough market
To understand the future market competition in the Chronic Cough market

1. Key Insights

2. Executive Summary of Chronic Cough

3. Competitive Intelligence Analysis for Chronic Cough

4. Chronic Cough: Market Overview at a Glance

4.1. Chronic Cough Total Market Share (%) Distribution in 2020
4.2. Chronic Cough Total Market Share (%) Distribution in 2034

5. Chronic Cough: Disease Background and Overview

5.1. Introduction
5.2. Sign and Symptoms
5.3. Pathophysiology
5.4. Risk Factors
5.5. Diagnosis

6. Patient Journey

7. Chronic Cough Epidemiology and Patient Population

7.1. Epidemiology Key Findings
7.2. Assumptions and Rationale: 7MM
7.3. Epidemiology Scenario: 7MM
- 7.3.1. Chronic Cough Epidemiology Scenario in the 7MM (2020-2034)
7.4. United States Epidemiology
- 7.4.1. Chronic Cough Epidemiology Scenario in the United States (2020-2034)
7.5. EU-5 Country-wise Epidemiology
- 7.5.1. Germany Epidemiology
  - 7.5.1.1. Chronic Cough Epidemiology Scenario in Germany (2020-2034)
- 7.5.2. France Epidemiology
  - 7.5.2.1. Chronic Cough Epidemiology Scenario in France (2020-2034)
- 7.5.3. Italy Epidemiology
  - 7.5.3.1. Chronic Cough Epidemiology Scenario in Italy (2020-2034)
- 7.5.4. Spain Epidemiology
  - 7.5.4.1. Chronic Cough Epidemiology Scenario in Spain (2020-2034)
- 7.5.5. United Kingdom Epidemiology
  - 7.5.5.1. Chronic Cough Epidemiology Scenario in the United Kingdom (2020-2034)
- 7.5.6. Japan Epidemiology
  - 7.5.6.1. Chronic Cough Epidemiology Scenario in Japan (2020-2034)

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Chronic Cough Treatment and Management
8.2. Chronic Cough Treatment Algorithm

9. Unmet Needs

10. Key Endpoints of Chronic Cough Treatment

11. Marketed Products

11.1. List of Marketed Products in the 7MM
11.2. Drug Name: Company Name
- 11.2.1. Product Description
- 11.2.2. Regulatory Milestones
- 11.2.3. Other Developmental Activities
- 11.2.4. Pivotal Clinical Trials
- 11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

12.1. Key Cross
12.2. Drug Name: Company Name
- 12.2.1. Product Description
- 12.2.2. Other Developmental Activities
- 12.2.3. Clinical Development
- 12.2.4. Safety and Efficacy
- 12.2.5. Product Profile

List to be continued in report

13. Chronic Cough: Seven Major Market Analysis

13.1. Key Findings
13.2. Chronic Cough Market Size in 7MM
13.3. Chronic Cough Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

15.1. United States: Market Size
- 15.1.1. Chronic Cough Total Market Size in the United States
- 15.1.2. Chronic Cough Market Size by Therapies in the United States
15.2. EU-5 countries: Market Size and Outlook
15.3. Germany Market Size
- 15.3.1. Chronic Cough Total Market Size in Germany
- 15.3.2. Chronic Cough Market Size by Therapies in Germany
15.4. France Market Size
- 15.4.1. Chronic Cough Total Market Size in France
- 15.4.2. Chronic Cough Market Size by Therapies in France
15.5. Italy Market Size
- 15.5.1. Chronic Cough Total Market Size in Italy
- 15.5.2. Chronic Cough Market Size by Therapies in Italy
15.6. Spain Market Size
- 15.6.1. Chronic Cough Total Market Size in Spain
- 15.6.2. Chronic Cough Market Size by Therapies in Spain
15.7. United Kingdom Market Size
- 15.7.1. Chronic Cough Total Market Size in the United Kingdom
- 15.7.2. Chronic Cough Market Size by Therapies in the United Kingdom
15.8. Japan Market Outlook
- 15.8.1. Japan Market Size
- 15.8.2. Chronic Cough Total Market Size in Japan
- 15.8.3. Chronic Cough Market Size by Therapies in Japan

慢性咳嗽 - 市場考察、疫学、市場予測（2034年）

Chronic Cough - Market Insight, Epidemiology, and Market Forecast - 2034

全表示

目次

第1章 重要考察

第2章 慢性咳嗽のエグゼクティブサマリー

第3章 慢性咳嗽の競合情報分析

第4章 慢性咳嗽：市場の概要

第5章 慢性咳嗽：疾患の背景と概要

第6章 ペイシェントジャーニー

第7章 慢性咳嗽の疫学と患者人口

第8章 治療アルゴリズム、現在の治療、医療行為

第9章 アンメットニーズ

第10章 慢性咳嗽治療の主な評価項目

第11章 上市済みの製品

第12章 新治療法

第13章 慢性咳嗽：主要7市場の分析

第14章 属性分析

第15章 主要7市場：市場見通し

第16章 慢性咳嗽のアクセスと償還の概要